Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Glycosylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115433250B reveals improved Spinosad A synthesis. Enhances yield and selectivity for reliable agrochemical intermediate supplier chains.
Patent CN118271376A reveals a novel allyl sulfone glycosyl donor for high-yield thioglycoside synthesis. Discover cost-effective pharmaceutical intermediate manufacturing solutions.
Novel cis-polyglucoside surfactant synthesis offers enhanced water solubility and eco-friendly production. Reliable supplier for cost reduction in surfactant manufacturing.
Novel 10-step route for fondaparinux sodium disaccharide fragment. Reduces steps, uses water solvent, enhances supply chain reliability for pharmaceutical intermediates.
Patent CN101381387A reveals a cost-effective, stereoselective route for Gemcitabine Hydrochloride, eliminating cryogenic conditions and improving supply chain reliability for API manufacturers.
Patent CN102127135B reveals a mild gold-catalyzed glycosylation method for nucleoside intermediates, offering superior regioselectivity and cost reduction in pharmaceutical manufacturing.
Novel SnCl4 addition order boosts yield >95% and purity >98%. Ideal for Capecitabine intermediates. Reliable pharmaceutical intermediate supplier.
Patent CN104926806B reveals a robust method for Lamivudine intermediates, offering high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN112940053B reveals a streamlined route for anti-HCV drugs, offering high purity and industrial scalability for reliable supply chains.
Novel Cobalt-catalyzed synthesis offers high yield and selectivity for alpha fused ring carbon glycoside intermediates. Enables cost reduction and supply chain reliability for pharmaceutical manufacturing partners globally.
Patent CN1989148A reveals a solid-state synthesis route for 1-alpha-halo-2,2-difluoro-2-deoxy-D-ribofuranose, enabling scalable Gemcitabine production with superior purity.
Patent CN111454270A discloses a novel six-membered ring nucleoside synthesis. Offers improved solubility and scalable routes for antiviral API manufacturing.
Novel Ni(II)-catalyzed method for high stereoselectivity 1,2-cis-glycosides. Reduces steps, improves yield, offers cost-effective API intermediate manufacturing.
Patent CN114163483A discloses a novel PTFAI-mediated alpha-glycosylation method offering high stereoselectivity and mild conditions for reliable pharmaceutical intermediate supply.
Patent CN109111490B introduces a novel halogenated pivaloyl glucopyranose route for SGLT2 inhibitors, offering superior stereoselectivity and industrial scalability for pharmaceutical manufacturing.
Patent CN102127135A reveals a mild, gold-catalyzed glycosylation method for pyrimidine and purine nucleosides, offering significant cost reduction in API manufacturing.
Patent CN111662260B reveals a 7-step synthesis of saffloneoside. Offers stable intermediates and scalable routes for cerebral ischemia drug development.
Novel synthesis route for 3-O-propargyl nucleoside avoids isomers ensuring high purity and scalable manufacturing for pharmaceutical intermediates globally.
Patent CN102942601A reveals a streamlined route for Fondaparinux sodium intermediates, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Novel catalytic glycosylation for Doxifluridine reduces Lewis acid usage and improves yield to 98%. A reliable API intermediate supplier for cost reduction.